GlassScriptPhysician profile
Kyla R Shultz
NPI 1689169575
$1,272.87
in general payments reported to CMS, 2019-2025
10 companies · $317 in 2025
The $317 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $56.12 · 2022: $33.26 · 2023: $703 · 2024: $163 · 2025: $317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $935 · Travel and Lodging: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $934.68 |
| Travel and Lodging | $248.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $862.68 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Vertex Pharmaceuticals Incorporated | $154.50 | 2025 | |
| Abbvie INC. | $91.11 | 2024-2025 | |
| Averitas Pharma INC. | $90.08 | 2023-2025 | Qutenza |
| Stryker Corporation | $23.36 | 2025 | Mild Device Kit |
| Collegium Pharmaceutical, INC. | $16.55 | 2021 | |
| Avanos Medical | $16.04 | 2022 | |
| Amgen INC. | $13.15 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $5.40 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyla Shultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.